OUP Management Co., LLC
- SEC CIK
- 0001880124
- Latest filing
- Nov 9, 2023
Holdings in Q2 2023
Holdings as of Jun 30, 2023, filed Aug 7, 2023. Long positions only; changes compare share counts with Q1 2023.
- Positions
- 12
- −2 vs. Q1 2023
- Portfolio value
- $58.6M
- +$8.53M (+17.0%) vs. Q1 2023
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| CNTACentessa Pharmaceuticals plc | SPONSORED ADS | 2,937,615 | $18.2M | 31.0% | 00.0% | Unchanged | History |
| DICEDICE Therapeutics, Inc. | COM | 268,346 | $12.5M | 21.3% | 00.0% | Unchanged | History |
| JBIOJade Biosciences, Inc. | COM | 603,762 | $10.4M | 17.7% | 00.0% | Unchanged | History |
| CYTCyteir Therapeutics, Inc. | COM | 2,459,572 | $6.39M | 10.9% | 00.0% | Unchanged | History |
| PMVPPMV Pharmaceuticals, Inc. | COM | 989,232 | $6.19M | 10.6% | 00.0% | Unchanged | History |
| VORVor Biopharma Inc. | COM | 374,714 | $1.16M | 2.0% | 00.0% | Unchanged | History |
| LENZLENZ Therapeutics, Inc. | COM | 406,308 | $1.06M | 1.8% | 00.0% | Unchanged | History |
| RNACCartesian Therapeutics, Inc. | COM | 862,543 | $966.0K | 1.6% | 00.0% | Unchanged | History |
| EFTReFFECTOR Therapeutics, Inc. | COM | 1,025,697 | $851.5K | 1.5% | 00.0% | Unchanged | History |
| DTILPrecision Biosciences Inc | COM | 1,123,913 | $591.2K | 1.0% | 00.0% | Unchanged | History |
| SPROSpero Therapeutics, Inc. | COM | 249,070 | $361.2K | 0.6% | 00.0% | Unchanged | History |
| QTTBQ32 Bio Inc. | COM | 64,000 | $56.6K | 0.1% | 00.0% | Unchanged | History |
Sold out since Q1 2023 (2)
Positions held at the end of Q1 2023 that are gone from this filing.